Please sign in to follow a disease.

POZ

Clinical trials for POZ explained in plain language.

Never miss a new study

Get alerted when new POZ trials appear

Sign up with your email to follow new studies for POZ, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New triple therapy aims to wipe out mantle cell lymphoma

Disease control Recruiting now

This study tests a combination of three drugs—pomalidomide, orelabrutinib, and zuberitamab—in people with untreated mantle cell lymphoma, a type of blood cancer. The goal is to see if the treatment can reduce cancer cells to undetectable levels after six cycles. Participants who …

Matched conditions: POZ

Sponsor: Peking University Third Hospital • Aim: Disease control

Last updated Jun 27, 2026 08:01 UTC

POZ

Get alerted when new POZ trials appear

New triple therapy aims to wipe out mantle cell lymphoma